Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0002018150-26-000003

Options or other derivatives

  • Chief Science Officer Virology acquired 97,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pauza Charles David · Chief Science Officer Virology

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-09 Grant or award : show line 1 in the form Stock Option (right to buy) +97,000 97,000 D
Loading xslF345X06/form4-07162026_040743.xml…